Registry for Bone Metastases

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The purpose of this study is to learn more about symptomatic bone metastases. This study is an international patient registry of people with symptomatic bone metastases. A patient registry is a database - a collection of health information - about a group of people, and it is usually focused on a specific diagnosis or condition.

Eligibility criteria

Qualifiers

Age ≥22 years

Biopsy-proven or clinically obvious metastatic bone disease

Symptomatic bone lesion requiring intervention

This includes but is not limited to radiotherapy, cryotherapy, radiofrequency ablation, operative fixation, prosthetic replacement, amputation, or any combination of the above

Disqualifiers

Age <22 years

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

500 Participants
are grouped into 1 trial group